Received Feb 13, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | — |
right ear that felt like a burning; The right ear burning pain; This non-serious case was reported by a nurse via call center representative and described the occurrence of ear pain in a 63-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. Concurrent medical conditions included ruptured intervertebral disc (ruptured disk L5-S1), asthma, blood cholesterol increased, attention deficit hyperactivity disorder and depression. Concomitant products included salbutamol (Albuterol), lisinopril, evolocumab (Repatha), lisdexamfetamine mesilate (Vyvanse) and desvenlafaxine succinate monohydrate (Pristiq). In FEB-2025, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced ear pain (Verbatim: right ear that felt like a burning) and burning sensation in ears (Verbatim: The right ear burning pain). The outcome of the ear pain and burning sensation in ears were resolved. It was unknown if the reporter considered the ear pain and burning sensation in ears to be related to Shingrix. It was unknown if the company considered the ear pain and burning sensation in ears to be related to Shingrix. Linked case(s) involving the same patient: US2026AMR018368 Additional Information: GSK Receipt Date:06-FEB-2026 The reporter stated that she received Shingrix. The reporter stated that after the first dose she had pain inside her right ear that felt like a burning. The right ear burning pain lasted a couple of weeks and then resolved. For tolerance of 2nd dose of Shingrix, refer case US2026AMR018368.; Sender's Comments: US-GSK-US2026AMR018368:SAME PATIENT 2nd dose
Asthma; Attention deficit hyperactivity disorder; Blood cholesterol increased; Depression; Ruptured intervertebral disc (ruptured disk L5-S1)
ALBUTEROL; LISINOPRIL; REPATHA; VYVANSE; PRISTIQ